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*Mycobacterium chelonae* is an opportunistic environmental pathogen ([@B1]) found in diverse habitats, including water, sewage, and soil ([@B2]). *M. chelonae* can cause corneal, cutaneous, and pulmonary infections in humans and other hosts. In many health care settings, the occurrence and spread of atypical mycobacterial infections, including those caused by *M. abscessus* and *M. chelonae*, have increased in prevalence in recent years. *M. chelonae* outbreaks have been attributed to factors ranging from resistance to glutaraldehyde, a commonly used hospital disinfectant ([@B3][@B4][@B6]) to contaminated medical equipment ([@B7]) and contaminated reagents ([@B8]).

We have sequenced and report here the first draft genome of a representative of the *M. chelonae* species. The type strain ATCC 35752 was originally isolated from the lungs of sea turtles (*Chelona corticata*), and shares phylogenetic similarity to human pathogens of this species. The genome of the *M. chelonae* type strain ATCC 35752 was assembled using 400-bp sequence reads generated from the Life Technologies Ion Torrent PGM (Thermo, Fisher Sciences, Carlsbad, CA) and 250 × 250 bp paired-end reads from the Illumina MiSeq (Illumina, Inc., San Diego, CA), at 220× coverage. Sequence reads were quality filtered using the Fastx_Toolkit (<http://hannonlab.cshl.edu/fastx_toolkit/>) and assembled into scaffolded contigs using the Newbler v2.9 (454 Life Sciences, Branford, CT) software package. The contigs were ordered in relation to the *M. abscessus* subsp. *abscessus* ATCC 19977 genome as a reference ([@B9]), employing the progressive Mauve 2.3.1 whole-genome alignment algorithm ([@B10]). Genomic features were annotated using the NCBI Prokaryotic Genome Annotation Pipeline ([@B11]).

The *M. chelonae* ATCC 35752 draft genome is a pseudomolecule composed of 24 contigs, with linking sequences of 100 N's in between each contig, resulting in a total assembly size of 4,898,027 bp and a G+C content of 63.96%. The average contig length is 204,084 bp with an *N*~50~ of 462,745 bp. A total of 4,489 coding sequences (CDSs) were predicted, including 3,274 CDSs (72.93%) with functional annotations and 1,215 CDSs (27.07%) annotated as hypothetical proteins. Our genome assembly contains 48 tRNAs, 1 noncoding RNA (ncRNA), and 1 rRNA cistron consisting of the 5S, 16S, and 23S rRNA genes. A comparative analysis between *M. chelonae* ATCC 35752 and *M. abscessus* ATCC 19977 revealed 3,803 orthologous CDSs that are shared between the two strains.

Whole-genome sequence alignments of *M. chelonae* ATCC 35752 and five representative *M. abscessus* genomes revealed an average of 620,054 single nucleotide polymorphisms (SNPs), including 628,647 SNPs compared to *M. abscessus* ATCC 19977, 629,586 SNPs compared to *M. bolletii* BD^T^, 631,431 SNPs compared to *M. bolletii* M24, 621,641 SNPs compared to *M. massiliense* GO-06, and 588,967 SNPs compared to *M. massiliense* CCUG 48898 (= JCM15300). These SNP differences (12.02 to 12.85% of the *M. chelonae* ATCC 35752 genome) underscore the genomic divergence between *M. chelonae* and its sister taxa (*M. abscessus* complex).
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The draft genome sequence of *M. chelonae* ATCC 35752 has been deposited in NCBI GenBank under the accession no. [CP010946](CP010946), BioProject no. PRJNA251569, and BioSample no. SAMN02837161.
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